Opexa Therapeutics Completes Patient Enrollment in Phase IIb Trial ...
Oxfordshire Bioscience Network (press release) - Oxford,UK
The trial design is a US multicentre, randomised, double-blind, placebo-controlled study of subcutaneous Tovaxin™ in subjects with Clinically Isolated ...
See all stories on this topic

Opexa testing T-cell vaccine for MS
United Press International - USA
THE WOODLANDS, Texas, May 17 (UPI) -- US firm Opexa Therapeutics said it has finished enrolling patients in a phase 2b study of its T-cell vaccine Tovaxin ...
See all stories on this topic